Vimarsana
Biggest News Aggregation in the World

Page 27 - Caredx Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caredx Inc Today - Breaking & Trending Today

CareDx, Inc (NASDAQ:CDNA) Insider Reginald Seeto Sells 2,819 Shares of Stock - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Insider Reginald Seeto Sells 2,819 Shares of Stock

CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,819 shares of the stock in a transaction dated Tuesday, May 2nd. The shares were sold at an average price of $8.12, for a total value of $22,890.28. Following the completion of the transaction, the insider now directly owns 534,996 shares in the company, valued […]

Source: wkrb13.com
Stanford Asks Supreme Court to Revisit Subject Matter Eligibility on Diagnostic Claims | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Stanford Asks Supreme Court to Revisit Subject Matter Eligibility on Diagnostic Claims | McDonnell Boehnen Hulbert & Berghoff LLP

"Hope springs eternal [in the human breast]" (Alexander Pope) and "Insanity is doing the same thing over and over and expecting different results" (the latter attributed variably to...

102,232 Shares in CareDx, Inc (NASDAQ:CDNA) Bought by Los Angeles Capital Management LLC - Vimarsana News

102,232 Shares in CareDx, Inc (NASDAQ:CDNA) Bought by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC purchased a new position in shares of CareDx, Inc (NASDAQ:CDNA – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 102,232 shares of the company’s stock, valued at approximately $1,166,000. Several other institutional investors and hedge […]

CareDx, Inc (NASDAQ:CDNA) Receives Average Rating of "Hold" from Analysts - Vimarsana News

CareDx, Inc (NASDAQ:CDNA) Receives Average Rating of "Hold" from Analysts

CareDx, Inc (NASDAQ:CDNA – Get Rating) has been given an average rating of “Hold” by the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price […]

Source: wkrb13.com
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference - Vimarsana News

CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

Posters and Symposium Highlight Utility of AlloSeq for HLA Typing, Organ Transplant Monitoring and Hematopoietic Stem Cell Monitoring ... | April 25, 2023